The system includes a low-profile implant design and also features a distinctive talar resurfacing option for preservation of talar bone and a tibia design that is compatible with the company’s existing INBONE II System.
The system is also available on a limited basis in certain countries outside the United States through the company’s direct sales organization.
More Articles on Devices:
5 Key Results: LDR’s Mobi-C Artificial Disc Replacement vs. ACDF
FDA Clears AccelSPINE’s Next Generation Minimally Invasive Spine System
Global Medical Device Market to Grow at 6.2% Annually Until 2018
